Left ventricular geometry and 24-h blood pressure profile in Cushing’s syndrome

[1]  L. Nieman,et al.  Cushing’s Syndrome , 2019, Canadian Family Practice Guidelines.

[2]  J. Anthony.  The Epidemiological Approach , 2018, The Routledge Handbook of Philosophy and Science of Addiction.

[3]  T. Gillebert,et al.  Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†. , 2015, European heart journal cardiovascular Imaging.

[4]  R. Netea-Maier,et al.  Persistent centripetal fat distribution and metabolic abnormalities in patients in long‐term remission of Cushing's syndrome , 2015, Clinical endocrinology.

[5]  A. Isidori,et al.  The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications , 2015, Journal of hypertension.

[6]  E. Laws,et al.  Acromegaly: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[7]  J. Kasprzak,et al.  Echocardiographic indices of left ventricular hypertrophy and diastolic function in hypertensive patients with preserved LVEF classified as dippers and non-dippers , 2013, Archives of medical science : AMS.

[8]  E. Horváth-Puhó,et al.  Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. , 2013, The Journal of clinical endocrinology and metabolism.

[9]  S. Iliceto,et al.  Coronary microvascular function in patients with Cushing’s syndrome , 2013, Endocrine.

[10]  F. Jaisser,et al.  Aldosterone, mineralocorticoid receptor, and heart failure , 2012, Molecular and Cellular Endocrinology.

[11]  F. Jaisser,et al.  Extrarenal effects of aldosterone , 2012, Current opinion in nephrology and hypertension.

[12]  G. Parati,et al.  Clinical relevance of cardiac structure and function abnormalities in patients with Cushing’s syndrome before and after cure , 2012, Clinical endocrinology.

[13]  G. Gamble,et al.  Mortality and morbidity in Cushing’s syndrome in New Zealand , 2011, Clinical endocrinology.

[14]  Yutaka Imai,et al.  European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults , 2010, Blood pressure monitoring.

[15]  G. Mancia,et al.  Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height2.7 , 2009, Journal of hypertension.

[16]  N. Sonino,et al.  Should we evaluate for cardiovascular disease in patients with Cushing’s syndrome? , 2009, Clinical endocrinology.

[17]  S. Ball,et al.  Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. , 2009, Cardiovascular research.

[18]  L. Jonasson,et al.  Inflammation and cortisol response in coronary artery disease , 2009, Annals of medicine.

[19]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[20]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension , 2007, Blood pressure.

[21]  Alice Stanton,et al.  Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study , 2005, Hypertension.

[22]  Roberto Sega,et al.  Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.

[23]  S. Zacharieva,et al.  Circadian blood pressure profile in patients with Cushing’s syndrome before and after treatment , 2004, Journal of endocrinological investigation.

[24]  M. Muiesan,et al.  Left ventricular structural and functional characteristics in Cushing's syndrome. , 2003, Journal of the American College of Cardiology.

[25]  Shumei Yang,et al.  Inhibitory effect of glucocorticoid on coronary artery endothelial function. , 2002, American journal of physiology. Heart and circulatory physiology.

[26]  Gianfranco Parati,et al.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .

[27]  P. Marzullo,et al.  Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. , 1999, The Journal of clinical endocrinology and metabolism.

[28]  P. Sótonyi,et al.  Cardiac nuclear hormone receptor mRNA in heart failure in man. , 1996, Life sciences.

[29]  G. Reboldi,et al.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.

[30]  M. Boscaro,et al.  Left ventricular structural characteristics in Cushing's syndrome. , 1994, Journal of human hypertension.

[31]  J. Etxabe,et al.  Morbidity and mortality in Cushing's disease: an epidemiological approach , 1994, Clinical endocrinology.

[32]  G. Schillaci,et al.  Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. , 1990, Circulation.

[33]  E. O’Brien,et al.  DIPPERS AND NON-DIPPERS , 1988, The Lancet.

[34]  Y. Imai,et al.  Altered circadian blood pressure rhythm in patients with Cushing's syndrome. , 1988, Hypertension.

[35]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[36]  S DeCandia,et al.  [Cushing's syndrome]. , 1951, Il Policlinico. Sezione pratica.

[37]  A. Fleming,et al.  Penicillin and streptomycin. , 1947, Lancet.

[38]  J. Voigt,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[39]  Jeroen J. Bax,et al.  Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome. , 2012, European journal of endocrinology.

[40]  R. Zulli,et al.  Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. , 1992, American journal of hypertension.